Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Viscoelastic Hydrogels Promote Bone Formation in 3D Cell Cultures

By LabMedica International staff writers
Posted on 15 Dec 2015
Stem cell researchers have devised a viscoelastic hydrogel matrix that encourages stem cells grown in three-dimensional culture to differentiate into bone tissue, which has promising applications in the realm of bone regeneration, growth, and healing.

Viscoelasticity is a molecular rearrangement. More...
When stress is applied to a viscoelastic material such as a polymer, some areas of the material's long polymer chains change positions. This movement or rearrangement is called creep. Polymers remain a solid material even when these parts of their chains are rearranging in order to accompany the stress, and as this occurs, it creates a back stress in the material. When the back stress is the same magnitude as the applied stress, the material no longer creeps. When the original stress is taken away, the accumulated back stresses will cause the polymer to return to its original form. The material creeps, which gives the prefix visco-, and the material fully recovers, which gives the suffix- elasticity.

Investigators at Harvard University (Cambridge, MA, USA) developed hydrogels for three-dimensional culture with different stress relaxation responses. They reported in the November 30, 2015, online edition of the journal Nature Materials that these types of materials enhanced cell spreading, proliferation, and the osteogenic differentiation of mesenchymal stem cells (MSCs) in cultures with gels with faster relaxation rates. Strikingly, MSCs formed a mineralized, collagen-1-rich matrix similar to bone in rapidly relaxing hydrogels. The effects of stress relaxation were mediated by adhesion-ligand binding, actomyosin contractility, and mechanical clustering of adhesion ligands.

"This work both provides new insight into the biology of regeneration, and is allowing us to design materials that actively promote tissue regeneration," said senior author Dr. David Mooney, professor of bioengineering at Harvard University. "In addition to introducing a new concept to the fields of mechanobiology and regenerative medicine, I expect this work will lead to an explosion of new ideas and research to examine how a number of other material mechanical properties influence cell behavior."

The Harvard University Office of Technology Development has filed a patent application and is actively exploring commercial opportunities for the viscoelastic cell culture technology.

Related Links:

Harvard University



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.